Aceperone

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C24H29FN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S69KXZ59AB, chemically known as acetamide, n-((1-(4-(4-fluorophenyl)-4-oxobutyl)-4-phenyl-4-piperidinyl)methyl)- (9ci) but generally known as aceperone, which bears US NIH Compound Identifier 13122. European Medicines Agency schedules Aceperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05212MIG. The term ACEPERONE is an International Non-Proprietary Name. ACEPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aceperone under HS 29333999 and SITC 51574. As of Q4 2014, ACEPERONE remains the US FDA Preferred Term for this commodity. Aceperone bears US NLM identifiers UMLS ID C0649938 and NCI Concept Code C72567. SMILES: FC1CCC(C(=O)CCCN2CCC(CC2)(CNC(=O)C)C2CCCCC2)CC1.